vs
Side-by-side financial comparison of Pasithea Therapeutics Corp. (KTTA) and TREASURE GLOBAL INC (TGL). Click either name above to swap in a different company.
Pasithea Therapeutics Corp. is the larger business by last-quarter revenue ($240.7K vs $182.5K, roughly 1.3× TREASURE GLOBAL INC). TREASURE GLOBAL INC runs the higher net margin — -1169.1% vs -2126.1%, a 957.0% gap on every dollar of revenue. TREASURE GLOBAL INC produced more free cash flow last quarter ($-2.4M vs $-4.5M).
Pasithea Therapeutics Corp. is a clinical-stage biopharmaceutical firm dedicated to developing novel treatments for psychiatric and neurological conditions including treatment-resistant mood disorders. It primarily operates in North American and European markets, targeting patient segments that lack effective existing treatment options.
Treasure Global Inc is a consumer technology company offering integrated digital commerce solutions, customer loyalty rewards programs, and cashless payment services. It primarily operates across Southeast Asian markets, serving individual users and small-to-medium enterprise clients.
KTTA vs TGL — Head-to-Head
Income Statement — Q4 FY2022 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $240.7K | $182.5K |
| Net Profit | $-5.1M | $-2.1M |
| Gross Margin | — | 0.7% |
| Operating Margin | -1679.5% | -953.5% |
| Net Margin | -2126.1% | -1169.1% |
| Revenue YoY | — | -12.0% |
| Net Profit YoY | — | -124.5% |
| EPS (diluted) | $-1.72 | $-0.38 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q3 25 | — | $182.5K | ||
| Q2 25 | — | $1.2M | ||
| Q1 25 | — | $666.5K | ||
| Q4 24 | — | $301.9K | ||
| Q3 24 | — | $207.4K | ||
| Q2 24 | — | $293.0K | ||
| Q1 24 | — | $1.6M | ||
| Q4 23 | — | $6.7M |
| Q3 25 | — | $-2.1M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | $1.3M | ||
| Q4 24 | — | $-232.3K | ||
| Q3 24 | — | $-950.7K | ||
| Q2 24 | — | — | ||
| Q1 24 | — | $-1.7M | ||
| Q4 23 | — | $-1.2M |
| Q3 25 | — | 0.7% | ||
| Q2 25 | — | 68.2% | ||
| Q1 25 | — | 73.0% | ||
| Q4 24 | — | 74.2% | ||
| Q3 24 | — | 83.0% | ||
| Q2 24 | — | 31.0% | ||
| Q1 24 | — | 13.6% | ||
| Q4 23 | — | 5.1% |
| Q3 25 | — | -953.5% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | -6.5% | ||
| Q4 24 | — | -229.5% | ||
| Q3 24 | — | -391.4% | ||
| Q2 24 | — | — | ||
| Q1 24 | — | -85.9% | ||
| Q4 23 | — | -16.2% |
| Q3 25 | — | -1169.1% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 189.0% | ||
| Q4 24 | — | -77.0% | ||
| Q3 24 | — | -458.5% | ||
| Q2 24 | — | — | ||
| Q1 24 | — | -107.3% | ||
| Q4 23 | — | -17.9% |
| Q3 25 | — | $-0.38 | ||
| Q2 25 | — | — | ||
| Q1 25 | — | $1.09 | ||
| Q4 24 | — | $-11.32 | ||
| Q3 24 | — | $-17.62 | ||
| Q2 24 | — | — | ||
| Q1 24 | — | $-116.03 | ||
| Q4 23 | — | $-2.22 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $33.1M | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $42.5M | $12.0M |
| Total Assets | $45.2M | $16.6M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | $2.5K | ||
| Q4 24 | — | $504.3K | ||
| Q3 24 | — | $44.1K | ||
| Q2 24 | — | $171.6K | ||
| Q1 24 | — | — | ||
| Q4 23 | — | — |
| Q3 25 | — | $12.0M | ||
| Q2 25 | — | $10.7M | ||
| Q1 25 | — | $29.1M | ||
| Q4 24 | — | $18.4M | ||
| Q3 24 | — | $6.3M | ||
| Q2 24 | — | $3.4M | ||
| Q1 24 | — | $3.1M | ||
| Q4 23 | — | $3.7M |
| Q3 25 | — | $16.6M | ||
| Q2 25 | — | $14.9M | ||
| Q1 25 | — | $30.4M | ||
| Q4 24 | — | $19.1M | ||
| Q3 24 | — | $7.1M | ||
| Q2 24 | — | $4.3M | ||
| Q1 24 | — | $4.2M | ||
| Q4 23 | — | $4.9M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-4.4M | $-1.8M |
| Free Cash FlowOCF − Capex | $-4.5M | $-2.4M |
| FCF MarginFCF / Revenue | -1874.2% | -1318.2% |
| Capex IntensityCapex / Revenue | 38.5% | 353.3% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-14.7M | — |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | — | $-1.8M | ||
| Q2 25 | — | $-9.5M | ||
| Q1 25 | — | $-4.2M | ||
| Q4 24 | — | $-606.2K | ||
| Q3 24 | — | $-976.3K | ||
| Q2 24 | — | $-4.7M | ||
| Q1 24 | — | $-1.1M | ||
| Q4 23 | — | $-1.2M |
| Q3 25 | — | $-2.4M | ||
| Q2 25 | — | $-9.5M | ||
| Q1 25 | — | $-4.2M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | $-4.7M | ||
| Q1 24 | — | $-1.1M | ||
| Q4 23 | — | $-1.2M |
| Q3 25 | — | -1318.2% | ||
| Q2 25 | — | -822.4% | ||
| Q1 25 | — | -635.6% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | -1614.2% | ||
| Q1 24 | — | -67.1% | ||
| Q4 23 | — | -17.9% |
| Q3 25 | — | 353.3% | ||
| Q2 25 | — | 1.3% | ||
| Q1 25 | — | 0.3% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 5.7% | ||
| Q1 24 | — | 0.0% | ||
| Q4 23 | — | 0.1% |
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | -3.36× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q4 23 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
